Jim Sullivan, Founder of Vanqua Bio

Jim Sullivan is the founder of Vanqua Bio. Vanqua Bio has raised $85M in total funding. Latest round: Series B. Based in Boston, MA.

About Jim Sullivan

Jim Sullivan is the Co-founder and Chief Executive Officer of Vanqua Bio, a Chicago-based biopharmaceutical company focused on developing next-generation medicines for neurodegenerative diseases. The company uses advanced insights into neuronal cell pathways and cutting-edge assays to create new therapies for conditions like Parkinson's, Alzheimer's, and ALS. Vanqua Bio secured an $85 million Series B financing round in September 2021, following an initial Series A funding from OrbiMed in 2019. Sullivan, a neuroscientist by training, has extensive experience in biotech and pharma, including a career at Abbvie where he contributed to the discovery and development of several therapies.

Jim Sullivan at a glance

More founders in Boston, MA (28)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades